Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03848754
Title Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medical College of Wisconsin

acute myeloid leukemia


Gemtuzumab ozogamicin + Pracinostat

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.